Oxaliplatin added to fluoropyrimidine/bevacizumab as initial therapy for unresectable metastatic colorectal cancer in older patients: a multicenter, randomized, open-label phase III trial (JCOG1018) - Takashima, A; Hamaguchi, T; Mizusawa, J; Colorectal Cancer Study Group in Japan Clinical Oncology Group (JCOG) (J Clin Oncol, 2024)